Viewing Study NCT06648057

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-30 @ 7:41 AM
Study NCT ID: NCT06648057
Status: RECRUITING
Last Update Posted: 2024-10-18
First Post: 2024-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Sponsor: CHA University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
None Cholangiocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lenvatinib View
None Pembrolizumab View
None Biliary Tract Cancer View
None Biomarker View
None RNA sequencing View